Oral contraceptives: Current status

被引:41
作者
Burkman, RT
机构
[1] Baystate Med Ctr, Springfield, MA USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
关键词
D O I
10.1097/00003081-200103000-00010
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
During the past four decades, oral contraceptives have remained a safe and effective method of birth control. Reductions in the estrogen and progestin dosages have significantly decreased the incidence of cardiovascular complications. The association between oral contraceptives and breast cancer appears to be primarily because of detection bias or possibly a promotional effect. Despite the changes in formulation, the problems related to side effects have not been totally solved. Because compliance and successful use is strongly affected by side effects, improvement in this area is probably the biggest challenge faced by developers of oral contraceptives, it is also clear that there are a growing number of significant noncontraceptive benefits that accrue in oral contraceptive users. Unfortunately, many women do not know about these benefits. Thus, one of the issues that providers need to continue to address is how to provide better information about oral contraceptives and contraception in general to patients.
引用
收藏
页码:62 / 72
页数:11
相关论文
共 29 条
  • [21] Clinical comparison of triphasic norgestimate/35 μg ethinyl estradiol and monophasic norethindrone acetate/20 μg ethinyl estradiol -: Cycle control, lipid effects, and user satisfaction
    Sulak, P
    Lippman, J
    Siu, C
    Massaro, J
    Godwin, A
    [J]. CONTRACEPTION, 1999, 59 (03) : 161 - 166
  • [22] Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms
    Sulak, PJ
    Cressman, BE
    Waldrop, E
    Holleman, S
    Kuehl, TJ
    [J]. OBSTETRICS AND GYNECOLOGY, 1997, 89 (02) : 179 - 183
  • [23] CONTRACEPTIVE FAILURE IN THE UNITED-STATES - A CRITICAL-REVIEW OF THE LITERATURE
    TRUSSELL, J
    KOST, K
    [J]. STUDIES IN FAMILY PLANNING, 1987, 18 (05) : 237 - 283
  • [24] Ursin G, 1997, CANCER RES, V57, P3678
  • [25] The use of oral contraception by adolescents for contraception, menstrual cycle problems or acne
    van Hooff, MHA
    Hirasing, RA
    Kaptein, MBM
    Koppenaal, C
    Voorhorst, FJ
    Schoemaker, J
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1998, 77 (09) : 898 - 904
  • [26] INCREASED RISK OF VENOUS THROMBOSIS IN ORAL-CONTRACEPTIVE USERS WHO ARE CARRIERS OF FACTOR-V LEIDEN MUTATION
    VANDENBROUCKE, JP
    KOSTER, T
    BRIET, E
    REITSMA, PH
    BERTINA, RM
    ROSENDAAL, FR
    [J]. LANCET, 1994, 344 (8935) : 1453 - 1457
  • [27] *WHO WORK GROUP, 1998, CARD DIS STER HORM C
  • [28] Blood coagulation and oral contraceptives -: A critical review
    Winkler, UH
    [J]. CONTRACEPTION, 1998, 57 (03) : 203 - 209
  • [29] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED COMPARISON OF THE IMPACT OF LOW-DOSE AND TRIPHASIC ORAL-CONTRACEPTIVES ON FOLLICULAR DEVELOPMENT
    YOUNG, RL
    SNABES, MC
    FRANK, ML
    REILLY, M
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1992, 167 (03) : 678 - 682